Item 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION

On October 27, 2009, QLT Inc. (the “Company”) reported its financial results for the third quarter ended September 30, 2009, and provided an update on its guidance to reflect the sale of the Company’s wholly-owned U.S. subsidiary, QLT USA, Inc., including the Eligard^® product line, on October 1, 2009.

The full text of the press release announcing such results and guidance is attached hereto as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. Such information shall not be deemed “filed” for purposes of Section 18 of the Securities and Exchange Act of 1934, as amended, and is not incorporated by reference into any filing of the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing.

ITEM 9.01 FINANCIAL STATEMENTS & EXHIBITS

d) Exhibits

Pursuant to the rules and regulations of the Securities and Exchange Commission, the attached exhibit is deemed to have been furnished to, but not filed with, the Securities and Exchange Commission:

Exhibit No.				Description
	99.1			Press Release dated October 27, 2009.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Exhibit Index

Exhibit No.				Description
	99.1			Press Release dated October 27, 2009.